- Abbasi AS,
Macalpin RN, Eber LM, Pearce ML. Echocardiographic diagnosis of
idiopathic hypertrophic cardiomyopathy without outflow obstruction.
Circulation 1972; 46: 897-904.
- Abelmann WH, Lorell BH. The challenge of cardiomyopathy. J Am
Coll Cardiol 1989; 13: 1219.
- Abelmann WH. Myocarditis and dilated cardiomyopathy (editorial)
West J Med 1989; 150: 458.
- Appleton CP, Hatle LK, Popp RL. Relation of transmitral flow velocity
patterns to left ventricular diastolic function: new insights from
a combined hemodynamic and Doppler echocardiographic study. J Am
Coll Cardiol 1988; 12: 426-440.
- Archard LC, Bowles EN, Olsen EGJ, Richardson PJ. Detection of
persistent Coxsackie B virus RNA in dilated cardiomyopathy and myocarditis.
Eur Heart J 1987 ; 8 (Suppl J) : 437-440.
- Bayés de Luna A. Electrocardiografía en las distintas
cardiopatías y en situaciones diversas. En: Bayés
de Luna A. Tratado de Electrocardiografía Clínica.
Madrid 1987; 493-494.
- Bonow RO, Dilsizian V, Rosing DR, Maron BJ, Bacharach SL, Green
MV. Verapamil-induced improvement in left ventricular diastolic
filling and increased exercise tolerance in patients with hypertrophic
cardiomyopathy: short and long term effects. Circulation 1985; 72:
853-864.
- Bourmayan C, Razavi A, Fournier C, Dussaule JC, Baragan J, Gerbaux
A, Gay J. Effect of propranolol on left ventricular relaxation in
hypertrophic cardiomyopathy: an echographic study. Am Heart J 1985;
109: 1311-1316.
- Braunwald E, Sonnenblick EH, Ross J Jr. Mechanisms of cardíac
contraction and relaxation. En : Braunwald E, ed. Heart Disease.
Philadelphia, Saunders 1988; 383-425.
- Brigden W. Uncommon myocardial disease. The noncoronary cardiomyopathies.
Lancet 1957; 2: 1179-1243.
- Caforio ALP, Bonifacio E, Steward JT et al. Novel organ-specific
circulating cardíac autoantibodies in dialted cardiomyoapathy.
J Am Coll Cardiol 1990; 15: 1527.
- Carvalho A, Brandao A, Martínez EE, et al Prognosis in
peripartum cardiomyopathy. Am J Cardiol 1989; 64: 540.
- Coughlin SS, Szklo M, Baughman K, Pearson TA. The epidemiology
of idiopathic dilated cardiomyopathy in a biracial community. Am
J Epidemiol 1990; 131: 48-56.
- Child JS, Perloff JK. The restrictive cardiomyopathies. Cardiol
Clin 1988; 6: 289.
- Dunkman WB, Johnson GR, Carson PE, Bhat G, Farrell L, Cohn JN,
Incidence of thromboembolic events in congestive heart failure.
Circulation 1993; 87(Suppl 6): 94-101.
- Epstein SE, Rosing DR. Verapamil: its potential for causing serious
complications in patients with hypertrophic cardiomyopathy. Circulation
1981; 64: 437-441.
- Estorch N, Carrió I, Artigas A et al. Volúmenes
biventriculares absolutos y gasto cardíaco por ventriculografía
isotópica. Rev Esp Cardiol 1988; 41: 97.
- Fananapazir Y, Chang AC, Epstein ND, McAreavey D. Prognostic determinants
in hypertrophic cardiomyopathy: prospective evaluation of therapeutic
strategy based on clinical, Holter, hemodynamic and electrophysiological
findings. Circulation 1992; 86: 730-740.
- Ferrans V J. Pathology anatomy of the dilated cardiomyopathies.
Am J Cardiol 1989; 64: 9C.
- Fitzpatrick AP, Shapiro LM, Rickards AF, Poole-Wilson PA. Familial
restrictive cardiomyopathy with atrioventricular block and skeletal
myopathy. Br Heart J 1990; 63: 114.
- Fowler MB, Laser JA, Hopkins GO, et al. Assessment of the Beta-Adrenergic
receptor pathway in the intact failing human heart: pregressive
receptor down-regulation and subsensitivity to agonist response.
Circulation 1986; 74: 1290-1302.
- Fragola PV, Autore C, Picelli A, et al. Familial idiopathic dilated
cardiomyopathy. Am Heart J 1988; 115: 912.
- Hochleitner M, Hortnagl H, Choi-Keung NG, Hortnagl H, Gschnitzer
F, Zechmann W. Usefulness of physiologic dual-chamber pacing in
drug-resistant idiopathic dilated cardiomyopathy. Am J Cardiol 1990;
66: 198-202.
- Hosenpud JD, McAnulty JH, Niles NR. Unexpected myocardial disease
in patients with life threatening arrhythmias. Br Heart J 1986;
46: 55.
- Hosenpud JD. Restrictive cardiomyopathy. In: Zipes DP and Rowlands
DJ (eds.). Progress in Cardiology. Philadelphia, 1989. Lea and Febiger.
p. 91.
- Iwase M, Yamauchi K, Maeda M, et al. Echocardiographic findings
in a case of Fabry's dsiease with aortic regurgitation and complete
AV block, and in his family members. J Cardiol 1988; 18: 589.
- Janicki JS, Myocardial collagen remodelling and left ventricular
diastolic function. Braz J Med Biol Res 1991 ; 25: 975-982.
- Johnson RA, Palacios IF. Non-dilated cardiomyopathies. Adv Intern
Med 1984; 30: 243-274.
- Karen A, Gottlieb S, T Zivoni D, et al. Mildly dylated congestive
cardiomyopathy. Use of prospective diagnostic criteria and description
of the clinical course without heart transpalntation. Circulation
1990; 81: 506.
- Komadja M, Jais P, Reeves F. Factors predicting mortality in idiopathic
dilated cardiomyopathy. Eur Heart J 1990; 11: 824-831.
- Levine B, Kulman J, Mayer L, et al. Elevated circulating levels
at tumor necrosis factor in severe chronic heart failure. N Engl
J Med 1990; 323: 236-241.
- Lundin L. Norheim I, Landelius J et al. Carcinoid Heart Disease:
Relacionship of circulating vasoactive substances to ultrasound-detectable
cardíac abnormalities. Circulation 1988; 77: 264.
- Maisch B, Herzum M, Hufnagel, Bethge C, Schonian U. Inmunosuppresive
treatment for myocarditis and dilated cardiomyopathy. European Heart
Journal 1995; 16S: 153-161.
- Marboe CC, Fenoglio JJ. Phatolgy and natural history of human
myocarditis. Phatol Inmunophatol Res 1988; 7: 226.
- Maron BJ, Cecchi F, McKenna, WJ. Risk factors and stratification
for sudden cardíac death in patients with hypertrophic cardiomyopathy.
Br Heart J 1994; 72 (supl): 13-18.
- Maron BJ, Spirito P. Impact of patient selection biases on the
perception of hypertrophic cardiomyopathy and its natural history.
Am J Cardiol 1993; 72: 970-972.
- Mason JW and O'Conell JB. Clinical merit of endomyocardial biopsy.
Circulation 1989; 79: 971.
- McKenna WJ, Adams KM, Poloniecki JD, Dickie S, Oakley CM, Krikler
DM, Goodwin JF. Long term survival with amiodarone in patients with
hypertrophic cardiomyopathy and ventricular tachycardia. Circulation
1989; 80: 6.
- McKenna WJ, England D, Doi YL, Deanfield JE, Oakley CM, Goodwin
JF. Arrhythmias in hypertrophic cardiomyopaty. Y. Influence on prognosis.
Br Heart J 1981; 46: 168-172.
- Millaire A, De Groote P, Decoulx E, Leroy O, Ducloux G. Outcome
after thrombolytic therapy of nine cases of myopericarditis misdiagnosed
as myocardial infarction. Eur Heart J 1995; 16: 333-338.
- Millaire A, Goullard L, Decoulx E, De Groote P, Houdas Y, Ducloux
G. Efficiency of disopyramide in hypertrophic cardiomyopathy during
stress states. Am J Cardiol 1992; 69: 423-442.
- Moodie DS, Baum JE, Gill CC, Ratliff NB. Endomyocardial fibrosis.
Diagnosis and surgical treatment of two cases occurring in the Unite
States. Clevelabd Clin Q 1986; 53: 159.
- O´Connell JB, Dec GW, Billingham ME, Goldenberg IF, Starling
RC, Mudge GH, Augustine SM, Costanzo-Nordin MR et al. Results of
cardíac transplantation in active myocarditis (Abstract).
J Heart Transplant 1989; 8: 99.
- Olsen EGJ, Spry CJF. Relation between eosinophilia and endomyocardial
disease. Prog Cardiovasc Dis 1985; 27: 241.
- Olson LJ, Edwards WD, Holmes DR Jr, et al. Endomyocardial biopsy
in hemochromatosis: Clinicopathologic correlates in six cases. J
Am Coll Cardiol 1989; 13: 116.
- Panza JA, Petrone RK, Fananazapir L, Maron BJ. Utility of continuous
Wave Doppler echocardiography in the noninvasive assessment of left
ventricular outflow tract pressure gradient in patients with hypertrophic
cardiomyopathy. J Am Coll Cardiol 1992; 19: 91-99.
- Peters NS, Poole-Wilson PA. Myocarditis: continuing clinical and
pathological confusion. Am Heart J 1991; 121: 942-947.
- Platzker Y, Pisman EZ, Pines A, Kellermann J. Unusual echocardiographic
pattern in Gaucher's disease. Cardiology 1985; 72: 144.
- Pouleur H. Role of Neurohormones in Ventricular Adaptation and
Failure. Am J Cardiol 1994; 73: 36C-39C.
- Pridie RB, Oakley CM. Mechanism of mitral regurgitation in hypertrophic
obstructive cardiomyopathy. Br Heart J 1970; 32: 203-208.
- Report of the WHO/ISFC task force on the definition and classification
of cardiomyopathies. Br Heart J 1980; 440: 672-675.
- Savage DD, Seides SF, Maron BJ, Myers DM, Epstein SE. Prevalence
of arrhythmias during 24-hours electrocardiographic monitoring and
exercise testing in patients with obstructive and non obstructive
hypertrophic cardiomyopathy. Circulation 1979; 59: 866-875.
- Schaper J, Froede R, Hein S, et al. Impairment of the myocardial
ultraestructure and changes of the cytoskeleton in dilated cardiomyopathy.
Circulation 1991; 83: 504.
- Shap PM, Gramiak R, Kramer DH. Ultrasound location of the left
ventricular outflow obstruction in hypertrophic obstructive cardiomyopathy.
Circulation 1969; 40: 3-11.
- Slade AKB, Sadoul N, Shapiro L, y cols. DDD pacing in hypertrophic
cardiomyopathy: a multicenter clinical experience. Heart 1996; 75:
44-9.
- Spirito P, McKenna WJ, Schultheiss HP. DDD pacing in obstructive
HCM (letter). Circulation 1995; 92: 1670-1671.
- Spirito P, Rapezzi C, Autore C, Bruzzi P, Bellone P, Ortolani
P, et al. Prognosis of asymptomatic patients with hypertrophic cardiomyopathy
and non sustained ventricular tachycardia. Circulation 1994; 90:
2743-2747.
- Stewart S, Schreiner B. Coexisting idiopathic hypertrophic subaortic
stenosis and coronary artery disease. Clinical implication and operative
management. J Thorac Cardiovasc Surg 1981; 82: 278.
- Teare RD. Asymmetrical hypertrophy of the heart in young adults.
Br Heart J 1958; 20: 1-8.
- The SOLVD Investigators. Effect of enalapril on mortality and
the development of heart failure in asymptomatic patients with reduced
left ventricular ejection fractions. N Engl J Med 1992; 327: 685-691.
- Tripodi D, McAreavey D, Epstein ND, Fenanapazir L. Impact of the
implantable defibrillator in hypertrophic cardiomyopathy patients
with at high risk for sudden death (resume). J Am Coll Cardiol 1993;
21: 352.
- Urbano-Márquez A, Estruch R, Navarro-López F, Grau
JM, Mont L, Rubin E. The effects of alcoholism on skeletal and cardíac
muscle. N Engl J Med 1989; 320: 409-415.
- Walsh TK, Vacek JL. Etanol and Herat disease. An underestimated
contributing factor. Postgrad Med 1986; 79: 60.
- WHO Technical Report Series: Cardiomyopahties. Report of a WHO
expert committee. Technical Report Series 697: 7; 1984.
- William Dec G, Palacios Y, Yasuda T, Fallon JT, An Khaw B, William
Strauss H, Haber E. Antimyosin antibody cardiac imaging: its role
in the diagnosis of myocarditis. J Am Coll Cardiol 1990; 16: 97-104.
- Wynne J, Braunwald E. Miocardiopatías y miocarditis: daños
tóxico, químico y físico al corazón
En: Braunwald E. Tratado de Cardiología. 4ª Ed (Vol
II). Madrid: Interamericana McGraw-Hill; 1993. p. 1557-1619.
|
